Haemonetics | HAE - Net Income

Stock Price
65.47
Daily Change
-1.19 -1.79%
Monthly
-20.27%
Yearly
-1.03%
Q1 Forecast
64.61

Haemonetics reported $38.68M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Avanos Medical USD -1.4M 75.4M Sep/2025
Baxter International USD -46M 137M Sep/2025
Becton, Dickinson and Co. USD 493M 81M Sep/2025
Boston Scientific USD 755M 42M Sep/2025
Cooper Companies USD 84.6M 13.7M Sep/2025
Fresenius EUR 344M 14M Sep/2025
Fresenius Medical Care EUR 274.8M 49.8M Sep/2025
Globus Medical USD 118.97M 83.88M Sep/2025
Haemonetics USD 38.68M 4.65M Sep/2025
Hologic USD 179.1M 8.2M Dec/2025
ICU Medical USD -3.4M 38.73M Sep/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
Masimo USD -100.4M 151.7M Sep/2025
Medtronic USD 1.37B 334M Sep/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Neogen USD -15.92M 52.26M Sep/2025
Quidel USD -733M 477.6M Sep/2025
ResMed USD 392.59M 44.06M Dec/2025
STAAR Surgical USD 8.88M 25.7M Sep/2025
Steris USD 191.9M 14.5M Sep/2025
Stryker USD 849M 10M Dec/2025
Teleflex USD -408.89M 531.47M Sep/2025
Terumo JPY 35.05B 6.79B Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
US Physical Therapy USD 13.14M 745K Sep/2025
Zimmer Biomet Holdings USD 230.9M 78.1M Sep/2025